Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Landos Biopharma, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 45 | 1 | 35 | −9 |
| Shares | 23.9M | 802 | 22.5M | −1.44M (−6.0%) |
| Value | $35.3M | $1.00K | $16.4M | −$18.9M (−53.6%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Landos Biopharma, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ergoteles LLC | 22,900 | $17.0K | 0.00% |
| Citadel Advisors LLC | 21,119 | $16.0K | 0.00% |
| Jane Street Group, LLC | 20,957 | $15.0K | 0.00% |
| Susquehanna International Group, LLP | 12,529 | $9.00K | 0.00% |
| Raymond James & Associates | 10,350 | $8.00K | 0.00% |
| Stratos Wealth Partners, LTD. | 10,000 | $7.00K | 0.00% |
| UBS Group AG | 1,243 | $1.00K | 0.00% |
| Credit Suisse AG | 3 | $0 | 0.00% |
Sold out (17)
Institutions that held Landos Biopharma, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| OrbiMed Advisors LLC | 283,217 | $418.0K |
| Jacobs Levy Equity Management, Inc | 158,875 | $234.0K |
| Walleye Capital LLC | 93,533 | $138.0K |
| Millennium Management LLC | 60,968 | $90.0K |
| Walleye Trading LLC | 33,132 | $49.0K |
| D. E. Shaw & Co., Inc. | 16,988 | $25.0K |
| Bank of New York Mellon Corp | 16,982 | $25.0K |
| STRS Ohio | 11,400 | $16.0K |
| Charles Schwab Investment Management Inc | 10,349 | $16.0K |
| New York State Common Retirement Fund | 2,700 | $4.00K |
| American International Group, Inc. | 2,324 | $3.00K |
| California State Teachers Retirement System | 1,959 | $3.00K |
| Barclays PLC | 761 | $1.00K |
| Legal & General Group Plc | 408 | $1.00K |
| Amalgamated Bank | 802 | $1.00K |
| Ameritas Investment Partners, Inc. | 515 | $1.00K |
| Manchester Capital Management LLC | 406 | $1.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Landos Biopharma, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 802 | $1.00K |